Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Institute of Medical Science (IMS), University of Toronto, Toronto, Canada; Centre for Criminology & Sociolegal Studies, University of Toronto, Toronto, Canada; Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil.
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, Canada.
Prev Med. 2018 Feb;107:109-113. doi: 10.1016/j.ypmed.2017.11.001. Epub 2017 Nov 7.
In Canada, opioid-related overdose mortality has steeply increased in recent years; as a substantial number of opioid-related deaths are related to fentanyl products, this phenomenon has widely been described as the 'fentanyl epidemic', also implying that these deaths are largely caused by clandestinely produced illicit fentanyl products. We examined numbers and rates of opioid- and fentanyl-related deaths in six pan-Canadian provinces with respective (coroner-based) data available from 2010 to 2016. While fentanyl-related deaths are clearly increasing from relatively low levels in all provinces, those increases are strongest in the two Western provinces (e.g., British Columbia, where fentanyl accounts for the majority of opioid deaths in 2016 and Alberta), and, to some extent, Ontario. However, fentanyl-related deaths remain a minority of deaths in Ontario (40%) and the remaining provinces (<25%). Furthermore, it is uncertain what proportion of fentanyl-related deaths is actually related to illicit fentanyl products. We conclude that fentanyl-related overdose deaths have risen - most strongly in the West - due to both a high availability of medical fentanyl products, as well as an influx of illegal fentanyl products. In most provinces, the majority of opioid deaths remain associated with other (non-fentanyl) products. Appropriate (prevention, treatment and policy) interventions need to be targeted at the full range of opioid deaths from different sources. Overall, a realistic framing of the social (e.g., media) discourse about the nature of the 'opioid overdose death crisis' is required, which is not exclusively an 'illicit fentanyl death crisis' even though this may be a socio-politically appealing image.
在加拿大,近年来与阿片类药物相关的过量死亡人数急剧增加;由于大量与阿片类药物相关的死亡与芬太尼产品有关,这种现象被广泛描述为“芬太尼流行”,这也意味着这些死亡在很大程度上是由秘密生产的非法芬太尼产品造成的。我们检查了六个加拿大省份的阿片类药物和芬太尼相关死亡人数,这些省份在 2010 年至 2016 年期间分别有(验尸官提供的)相关数据。虽然所有省份的芬太尼相关死亡人数都在从相对较低的水平上明显增加,但在两个西部省份(例如不列颠哥伦比亚省,2016 年芬太尼占阿片类药物死亡的大多数)和安大略省,这种增长最为强劲。然而,在安大略省,芬太尼相关死亡人数仍然只占死亡人数的一小部分(40%),其余省份则更少(<25%)。此外,芬太尼相关死亡人数中有多少实际上与非法芬太尼产品有关还不确定。我们的结论是,由于医疗用芬太尼产品的大量供应,以及非法芬太尼产品的涌入,芬太尼相关的过量死亡人数在西部各州急剧上升。在大多数省份,大多数阿片类药物死亡仍然与其他(非芬太尼)产品有关。需要针对不同来源的阿片类药物死亡采取适当的(预防、治疗和政策)干预措施。总的来说,需要对社会(如媒体)对“阿片类药物过量死亡危机”性质的讨论进行现实的框架构建,即使这可能是一个具有社会政治吸引力的形象,但这种危机并不完全是“非法芬太尼死亡危机”。
Health Promot Chronic Dis Prev Can. 2018-6
Transl Psychiatry. 2019-11-11
Psychiatr Serv. 2017-10-2
Int J Environ Res Public Health. 2024-4-4
Addict Sci Clin Pract. 2024-9-29
Psychoactives. 2023-11-3
Health Promot Chronic Dis Prev Can. 2024-5
Ther Adv Psychopharmacol. 2022-12-10
J Pain. 2022-12
Subst Abuse Treat Prev Policy. 2021-9-14
Int J Environ Res Public Health. 2021-7-14